Traynor Capital Management Inc. raised its holdings in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 61.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,528 shares of the medical research company’s stock after purchasing an additional 9,706 shares […]
Edmonds Duncan Registered Investment Advisors LLC bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,352 shares of the medical research company’s stock, valued at approximately $227,000. A number of […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) Director James Edward Doyle sold 1,402 shares of Exact Sciences stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $90.51, for a total transaction of $126,895.02. Following the completion of the transaction, the director now directly owns 54,110 shares of […]
ExodusPoint Capital Management LP trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 17.8% during the fourth quarter, Holdings Channel reports. The firm owned 58,292 shares of the medical research company’s stock after selling 12,600 shares during the period. ExodusPoint Capital Management LP’s holdings in Exact Sciences were worth $2,886,000 […]
Thematics Asset Management bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 47,771 shares of the medical research company’s stock, valued at approximately $2,365,000. A number of other institutional investors have also […]